July 2022 साठी 11 सर्वोत्तम कामगिरी करणारे म्युच्युअल फंड | Fincash.com

Table of Contents

July 2022 साठी सर्वोत्तम कामगिरी करणारे म्युच्युअल फंड

Updated on July 23, 2025 , 37425 views

खालील निकषांवर आधारित आम्ही निवडले आहेसर्वोत्तम कामगिरी करणारे म्युच्युअल फंड July, 2022 साठी. आम्ही किमान निधी फिल्टर केला आहे100 कोटी सर्व श्रेण्यांमधील व्यवस्थापनाखालील मालमत्ता.

Ready to Invest?
Talk to our investment specialist

निकष

AUM > 100 कोटी
फंड वय > 1 वर्ष
सर्व श्रेणीतील निधी
1 महिन्याच्या रिटर्नवर क्रमवारी लावली.
निधीच्या श्रेणी
- इक्विटी
- कर्ज
- संकरित
- सोने
- जागतिक निधी

म्युच्युअल फंडात ऑनलाइन गुंतवणूक कशी करावी?

Fincash.com वर आजीवन मोफत गुंतवणूक खाते उघडा.

तुमची नोंदणी आणि KYC प्रक्रिया पूर्ण करा

दस्तऐवज अपलोड करा (PAN, आधार इ.).आणि, तुम्ही गुंतवणूक करण्यास तयार आहात!

सुरु करूया

शीर्ष ११ सर्वोत्तम म्युच्युअल फंड July 2022

Fund	NAV	Net Assets (Cr)	Min Investment	Min SIP Investment	1 MO (%)	3 MO (%)	6 MO (%)	1 YR (%)	3 YR (%)	5 YR (%)	2024 (%)
DSP BlackRock World Mining Fund Growth	₹18.4774 ↓ -0.22	₹130	1,000	500	8.5	13.4	16.3	14.4	12.5	12.5	-8.1
ICICI Prudential US Bluechip Equity Fund Growth	₹66.76 ↑ 0.41	₹3,113	5,000	100	7.2	16.4	3.5	14.1	15.3	14.7	10.4
Edelweiss ASEAN Equity Off-shore Fund Growth	₹30.327 ↑ 0.17	₹108	5,000	1,000	5.9	12.5	7.9	19.8	10.9	9.5	14.5
Nippon India Japan Equity Fund Growth	₹20.9924 ↓ -0.29	₹272	5,000	100	5.8	9.8	10.3	14	14	8.7	9.3
SBI Healthcare Opportunities Fund Growth	₹442.163 ↑ 1.93	₹3,849	5,000	500	5.8	4.2	7	19.8	28.5	23.9	42.2
UTI Healthcare Fund Growth	₹296.484 ↓ -0.52	₹1,099	5,000	500	5.1	10.4	8.9	17	26.8	22	42.9
Franklin Asian Equity Fund Growth	₹31.9439 ↑ 0.03	₹263	5,000	500	5	15.9	13.1	14.9	7.9	4.6	14.4
DSP BlackRock US Flexible Equity Fund Growth	₹65.0543 ↑ 0.80	₹935	1,000	500	4.9	26.5	5.5	20.8	17.4	17	17.8
HDFC Long Term Advantage Fund Growth	₹595.168 ↑ 0.28	₹1,318	500	500	4.4	1.2	15.4	35.5	20.6	17.4
Aditya Birla Sun Life International Equity Fund - Plan A Growth	₹42.1632 ↑ 0.12	₹215	1,000	1,000	4.3	14.9	16.1	27.5	13.3	11.7	7.4
TATA India Pharma & Healthcare Fund Growth	₹30.9778 ↑ 0.04	₹1,282	5,000	150	4.2	6	4.8	10.6	24.5	21.8	40.4
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 24 Jul 25

*खाली यादी दिली आहेशीर्ष म्युच्युअल फंड July साठी, 2022 येतमालमत्ता >= 100 कोटी

1. DSP BlackRock World Mining Fund

The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in the units of BlackRock Global Funds – World Mining Fund. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time.

DSP BlackRock World Mining Fund is a Equity - Global fund was launched on 29 Dec 09. It is a fund with High risk and has given a CAGR/Annualized return of 4% since its launch. Ranked 19 in Global category. Return for 2024 was -8.1% , 2023 was 0% and 2022 was 12.2% .

Below is the key information for DSP BlackRock World Mining Fund

DSP BlackRock World Mining Fund Growth
Launch Date	29 Dec 09
NAV (24 Jul 25)	₹18.4774 ↓ -0.22 (-1.20 %)
Net Assets (Cr)	₹130 on 30 Jun 25
Category	Equity - Global
AMC	DSP BlackRock Invmt Managers Pvt. Ltd.
Rating	☆☆☆
Risk	High
Expense Ratio	1.1
Sharpe Ratio	0.06
Information Ratio	0
Alpha Ratio	0
Min Investment	1,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹15,758
30 Jun 22	₹14,627
30 Jun 23	₹17,041
30 Jun 24	₹17,385
30 Jun 25	₹18,512

DSP BlackRock World Mining Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹415,684.
Net Profit of ₹115,684 Invest Now

Returns for DSP BlackRock World Mining Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	8.5%
3 Month	13.4%
6 Month	16.3%
1 Year	14.4%
3 Year	12.5%
5 Year	12.5%
10 Year
15 Year
Since launch	4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	-8.1%
2023	0%
2022	12.2%
2021	18%
2020	34.9%
2019	21.5%
2018	-9.4%
2017	21.1%
2016	49.7%
2015	-36%

Fund Manager information for DSP BlackRock World Mining Fund

Name	Since	Tenure
Jay Kothari	1 Mar 13	12.34 Yr.

Data below for DSP BlackRock World Mining Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Basic Materials	95.17%
Energy	1.11%

Asset Allocation

Asset Class	Value
Cash	3.71%
Equity	96.27%
Debt	0.02%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BGF World Mining I2 Investment Fund \| -	99%	₹126 Cr	202,992 ↓ -3,445
Treps / Reverse Repo Investments CBLO/Reverse Repo \| -	1%	₹1 Cr
Net Receivables/Payables Net Current Assets \| -	0%	-₹1 Cr

2. ICICI Prudential US Bluechip Equity Fund

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities (including ADRs/GDRs issued by Indian and foreign companies) of companies listed on New York Stock Exchange and/or NASDAQ. However, there can be no assurance that the investment objective of the Scheme will be realized.

ICICI Prudential US Bluechip Equity Fund is a Equity - Global fund was launched on 6 Jul 12. It is a fund with High risk and has given a CAGR/Annualized return of 15.7% since its launch. Ranked 7 in Global category. Return for 2024 was 10.4% , 2023 was 30.6% and 2022 was -7.1% .

Below is the key information for ICICI Prudential US Bluechip Equity Fund

ICICI Prudential US Bluechip Equity Fund Growth
Launch Date	6 Jul 12
NAV (24 Jul 25)	₹66.76 ↑ 0.41 (0.62 %)
Net Assets (Cr)	₹3,113 on 30 Jun 25
Category	Equity - Global
AMC	ICICI Prudential Asset Management Company Limited
Rating	☆☆☆☆
Risk	High
Expense Ratio	2.18
Sharpe Ratio	0.22
Information Ratio	-0.91
Alpha Ratio	-6.41
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-3 Months (3%),3-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹13,701
30 Jun 22	₹12,219
30 Jun 23	₹15,905
30 Jun 24	₹17,450
30 Jun 25	₹19,038

ICICI Prudential US Bluechip Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for ICICI Prudential US Bluechip Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	7.2%
3 Month	16.4%
6 Month	3.5%
1 Year	14.1%
3 Year	15.3%
5 Year	14.7%
10 Year
15 Year
Since launch	15.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	10.4%
2023	30.6%
2022	-7.1%
2021	22.5%
2020	18.6%
2019	34.3%
2018	5.2%
2017	14.1%
2016	11.6%
2015	0.7%

Fund Manager information for ICICI Prudential US Bluechip Equity Fund

Name	Since	Tenure
Ritesh Lunawat	13 Sep 24	0.79 Yr.
Sharmila D’mello	1 Jul 22	3 Yr.
Nitya Mishra	4 Nov 24	0.65 Yr.

Data below for ICICI Prudential US Bluechip Equity Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Health Care	27.21%
Technology	21.92%
Industrials	13.9%
Consumer Defensive	11.93%
Financial Services	8.13%
Communication Services	5.47%
Basic Materials	5.04%
Consumer Cyclical	3.86%
Energy	0.55%

Asset Allocation

Asset Class	Value
Cash	1.99%
Equity	98.01%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Veeva Systems Inc Class A (Healthcare) Equity, Since 31 Oct 21 \| VEEV	3%	₹92 Cr	38,291
West Pharmaceutical Services Inc (Healthcare) Equity, Since 31 Dec 24 \| WST	3%	₹85 Cr	47,000
Huntington Ingalls Industries Inc (Industrials) Equity, Since 29 Feb 24 \| HII	3%	₹81 Cr	42,405 ↓ -11,786
Brown-Forman Corp Registered Shs -B- Non Vtg (Consumer Defensive) Equity, Since 30 Jun 24 \| BF.B	3%	₹80 Cr	281,600
Allegion PLC (Industrials) Equity, Since 30 Sep 22 \| ALLE	2%	₹74 Cr	60,986
Zimmer Biomet Holdings Inc (Healthcare) Equity, Since 31 Mar 17 \| ZBH	2%	₹74 Cr	93,999 ↑ 9,000
Microchip Technology Inc (Technology) Equity, Since 30 Sep 21 \| MCHP	2%	₹73 Cr	148,020 ↓ -23,000
Pfizer Inc (Healthcare) Equity, Since 31 Mar 23 \| PFE	2%	₹73 Cr	362,963
Monolithic Power Systems Inc (Technology) Equity, Since 31 Dec 24 \| MPWR	2%	₹73 Cr	12,877 ↓ -2,000
Corteva Inc (Basic Materials) Equity, Since 30 Jun 23 \| 2X0	2%	₹73 Cr	119,840 ↓ -28,000

3. Edelweiss ASEAN Equity Off-shore Fund

The primary investment objective of the Scheme is to provide long term capital growth by investing predominantly in JPMorgan Funds – JF ASEAN Equity Fund, an equity fund which invests primarily in companies of countries which are members of the Association of South East Asian Nations (ASEAN). However, there can be no assurance that the investment objective of the Scheme will be realized.

Edelweiss ASEAN Equity Off-shore Fund is a Equity - Global fund was launched on 1 Jul 11. It is a fund with High risk and has given a CAGR/Annualized return of 8.2% since its launch. Ranked 18 in Global category. Return for 2024 was 14.5% , 2023 was -1.4% and 2022 was 4.8% .

Below is the key information for Edelweiss ASEAN Equity Off-shore Fund

Edelweiss ASEAN Equity Off-shore Fund Growth
Launch Date	1 Jul 11
NAV (24 Jul 25)	₹30.327 ↑ 0.17 (0.55 %)
Net Assets (Cr)	₹108 on 30 Jun 25
Category	Equity - Global
AMC	Edelweiss Asset Management Limited
Rating	☆☆☆
Risk	High
Expense Ratio	1.42
Sharpe Ratio	0.87
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹11,912
30 Jun 22	₹11,419
30 Jun 23	₹12,528
30 Jun 24	₹12,837
30 Jun 25	₹15,108

Edelweiss ASEAN Equity Off-shore Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹385,859.
Net Profit of ₹85,859 Invest Now

Returns for Edelweiss ASEAN Equity Off-shore Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	5.9%
3 Month	12.5%
6 Month	7.9%
1 Year	19.8%
3 Year	10.9%
5 Year	9.5%
10 Year
15 Year
Since launch	8.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	14.5%
2023	-1.4%
2022	4.8%
2021	6.3%
2020	2.3%
2019	12%
2018	-2.1%
2017	21.9%
2016	9.6%
2015	-11.1%

Fund Manager information for Edelweiss ASEAN Equity Off-shore Fund

Name	Since	Tenure
Bhavesh Jain	27 Sep 19	5.76 Yr.
Bharat Lahoti	1 Oct 21	3.75 Yr.

Data below for Edelweiss ASEAN Equity Off-shore Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Financial Services	46.2%
Consumer Cyclical	11.87%
Industrials	9.7%
Real Estate	7.94%
Communication Services	5.67%
Consumer Defensive	4.49%
Utility	3.8%
Technology	2.84%
Health Care	2.79%
Energy	1.53%
Basic Materials	0.57%

Asset Allocation

Asset Class	Value
Cash	2.59%
Equity	97.41%
Other	0%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
JPM ASEAN Equity I (acc) USD Investment Fund \| -	98%	₹106 Cr	61,893 ↑ 2,770
Clearing Corporation Of India Ltd. CBLO/Reverse Repo \| -	1%	₹2 Cr
Net Receivables/(Payables) CBLO \| -	0%	₹0 Cr
Accrued Interest CBLO/Reverse Repo \| -	0%	₹0 Cr

4. Nippon India Japan Equity Fund

The primary investment objective of Reliance Japan Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on the recognized stock exchanges of Japan and the secondary objective is to generate consistent returns by investing in debt and money market securities of India. However, there can be no assurance or guarantee that the investment objective of the scheme will be achieved.

Nippon India Japan Equity Fund is a Equity - Global fund was launched on 26 Aug 14. It is a fund with High risk and has given a CAGR/Annualized return of 6.9% since its launch. Ranked 9 in Global category. Return for 2024 was 9.3% , 2023 was 18.7% and 2022 was -15.3% .

Below is the key information for Nippon India Japan Equity Fund

Nippon India Japan Equity Fund Growth
Launch Date	26 Aug 14
NAV (25 Jul 25)	₹20.9924 ↓ -0.29 (-1.36 %)
Net Assets (Cr)	₹272 on 30 Jun 25
Category	Equity - Global
AMC	Nippon Life Asset Management Ltd.
Rating	☆☆☆☆
Risk	High
Expense Ratio	2.44
Sharpe Ratio	0.73
Information Ratio	-1.07
Alpha Ratio	-3.97
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹12,269
30 Jun 22	₹9,897
30 Jun 23	₹11,673
30 Jun 24	₹12,853
30 Jun 25	₹14,916

Nippon India Japan Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹376,357.
Net Profit of ₹76,357 Invest Now

Returns for Nippon India Japan Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	5.8%
3 Month	9.8%
6 Month	10.3%
1 Year	14%
3 Year	14%
5 Year	8.7%
10 Year
15 Year
Since launch	6.9%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	9.3%
2023	18.7%
2022	-15.3%
2021	5.7%
2020
2019
2018
2017
2016
2015

Fund Manager information for Nippon India Japan Equity Fund

Name	Since	Tenure
Kinjal Desai	25 May 18	7.1 Yr.

Data below for Nippon India Japan Equity Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Industrials	28.78%
Consumer Cyclical	16.07%
Technology	12.69%
Financial Services	12.51%
Consumer Defensive	9.92%
Communication Services	6.73%
Real Estate	6.33%
Basic Materials	3.25%

Asset Allocation

Asset Class	Value
Cash	3.72%
Equity	96.28%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Ajinomoto Co Inc (Consumer Defensive) Equity, Since 30 Jun 23 \| 2802	4%	₹10 Cr	46,800
BayCurrent Inc (Industrials) Equity, Since 30 Jun 22 \| 6532	4%	₹10 Cr	21,400
Sumitomo Electric Industries Ltd (Consumer Cyclical) Equity, Since 30 Jun 24 \| 5802	4%	₹10 Cr	53,900
Nippon Telegraph & Telephone Corp (Communication Services) Equity, Since 30 Jun 22 \| 9432	3%	₹9 Cr	963,700
Hitachi Ltd (Industrials) Equity, Since 31 Aug 14 \| 6501	3%	₹9 Cr	38,100
Mitsui & Co Ltd (Industrials) Equity, Since 30 Jun 24 \| MTS1	3%	₹9 Cr	50,800
Recruit Holdings Co Ltd (Communication Services) Equity, Since 30 Jun 23 \| 6098	3%	₹9 Cr	17,700
Mitsui Fudosan Co Ltd (Real Estate) Equity, Since 31 Aug 14 \| 8801	3%	₹9 Cr	110,000
Tokio Marine Holdings Inc (Financial Services) Equity, Since 30 Jun 22 \| MH6	3%	₹9 Cr	24,900
Sony Group Corp (Technology) Equity, Since 30 Jun 21 \| SON1	3%	₹9 Cr	39,700

5. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 15.7% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (24 Jul 25)	₹442.163 ↑ 1.93 (0.44 %)
Net Assets (Cr)	₹3,849 on 30 Jun 25
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	2.09
Sharpe Ratio	0.87
Information Ratio	0.37
Alpha Ratio	2.79
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹15,902
30 Jun 22	₹13,774
30 Jun 23	₹17,755
30 Jun 24	₹24,634
30 Jun 25	₹29,799

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹543,623.
Net Profit of ₹243,623 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	5.8%
3 Month	4.2%
6 Month	7%
1 Year	19.8%
3 Year	28.5%
5 Year	23.9%
10 Year
15 Year
Since launch	15.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%
2015	27.1%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	14.01 Yr.

Data below for SBI Healthcare Opportunities Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Health Care	90.06%
Basic Materials	6.02%

Asset Allocation

Asset Class	Value
Cash	3.92%
Equity	96.08%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	13%	₹470 Cr	2,800,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	7%	₹273 Cr	412,222 ↑ 12,222
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	6%	₹236 Cr	2,100,000
Lonza Group Ltd ADR (Healthcare) Equity, Since 31 Jan 24 \| LZAGY	5%	₹178 Cr	300,000
Cipla Ltd (Healthcare) Equity, Since 31 Aug 16 \| CIPLA	5%	₹176 Cr	1,200,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 23 \| LUPIN	4%	₹164 Cr	840,000
Mankind Pharma Ltd (Healthcare) Equity, Since 30 Apr 23 \| MANKIND	4%	₹138 Cr	560,000
Krishna Institute of Medical Sciences Ltd (Healthcare) Equity, Since 30 Nov 22 \| 543308	3%	₹123 Cr	1,800,000 ↓ -234,372
Fortis Healthcare Ltd (Healthcare) Equity, Since 30 Apr 21 \| FORTIS	3%	₹119 Cr	1,680,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	3%	₹118 Cr	1,000,000

6. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 15.1% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (25 Jul 25)	₹296.484 ↓ -0.52 (-0.18 %)
Net Assets (Cr)	₹1,099 on 30 Jun 25
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.38
Sharpe Ratio	0.75
Information Ratio	-0.29
Alpha Ratio	1.14
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹15,774
30 Jun 22	₹13,373
30 Jun 23	₹15,783
30 Jun 24	₹22,500
30 Jun 25	₹27,347

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹530,691.
Net Profit of ₹230,691 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	5.1%
3 Month	10.4%
6 Month	8.9%
1 Year	17%
3 Year	26.8%
5 Year	22%
10 Year
15 Year
Since launch	15.1%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	3.08 Yr.

Data below for UTI Healthcare Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Health Care	96.34%
Basic Materials	0.99%

Asset Allocation

Asset Class	Value
Cash	2.67%
Equity	97.33%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	10%	₹111 Cr	661,016 ↓ -11,873
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| CIPLA	6%	₹59 Cr	400,000
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	5%	₹50 Cr	396,000
Procter & Gamble Health Ltd (Healthcare) Equity, Since 31 Dec 20 \| PGHL	4%	₹46 Cr	80,283 ↑ 520
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| AJANTPHARM	4%	₹43 Cr	172,829
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| GLENMARK	4%	₹40 Cr	275,250
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹39 Cr	56,271
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	3%	₹37 Cr	56,000
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| FORTIS	3%	₹33 Cr	465,000
Eris Lifesciences Ltd Registered Shs (Healthcare) Equity, Since 31 Mar 19 \| ERIS	3%	₹32 Cr	204,451 ↓ -8,479

7. Franklin Asian Equity Fund

An open-end diversified equity fund that seeks to provide medium to long term appreciation through investments primarily in Asian Companies / sectors (excluding Japan) with long term potential across market capitalisation.

Franklin Asian Equity Fund is a Equity - Global fund was launched on 16 Jan 08. It is a fund with High risk and has given a CAGR/Annualized return of 6.9% since its launch. Ranked 1 in Global category. Return for 2024 was 14.4% , 2023 was 0.7% and 2022 was -14.5% .

Below is the key information for Franklin Asian Equity Fund

Franklin Asian Equity Fund Growth
Launch Date	16 Jan 08
NAV (24 Jul 25)	₹31.9439 ↑ 0.03 (0.09 %)
Net Assets (Cr)	₹263 on 30 Jun 25
Category	Equity - Global
AMC	Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	2.5
Sharpe Ratio	0.42
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-3 Years (1%),3 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹13,356
30 Jun 22	₹10,522
30 Jun 23	₹10,567
30 Jun 24	₹11,501
30 Jun 25	₹12,768

Franklin Asian Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹340,450.
Net Profit of ₹40,450 Invest Now

Returns for Franklin Asian Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	5%
3 Month	15.9%
6 Month	13.1%
1 Year	14.9%
3 Year	7.9%
5 Year	4.6%
10 Year
15 Year
Since launch	6.9%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	14.4%
2023	0.7%
2022	-14.5%
2021	-5.9%
2020	25.8%
2019	28.2%
2018	-13.6%
2017	35.5%
2016	7.2%
2015	-4.6%

Fund Manager information for Franklin Asian Equity Fund

Name	Since	Tenure
Sandeep Manam	18 Oct 21	3.62 Yr.
Shyam Sriram	26 Sep 24	0.68 Yr.

Data below for Franklin Asian Equity Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Consumer Cyclical	25%
Financial Services	23.22%
Technology	21%
Industrials	6.82%
Consumer Defensive	5.07%
Communication Services	4.71%
Health Care	4.33%
Real Estate	2.28%
Basic Materials	1.85%
Utility	1.38%

Asset Allocation

Asset Class	Value
Cash	4.35%
Equity	95.65%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Taiwan Semiconductor Manufacturing Co Ltd (Technology) Equity, Since 31 Mar 09 \| 2330	12%	₹31 Cr	111,000
ICICI Bank Ltd (Financial Services) Equity, Since 31 Mar 24 \| ICICIBANK	5%	₹13 Cr	87,497
HDFC Bank Ltd (Financial Services) Equity, Since 31 Mar 24 \| HDFCBANK	5%	₹12 Cr	64,250
Tencent Holdings Ltd (Communication Services) Equity, Since 31 Jul 14 \| 00700	5%	₹12 Cr	21,600
Alibaba Group Holding Ltd Ordinary Shares (Consumer Cyclical) Equity, Since 31 Dec 20 \| 09988	3%	₹8 Cr	65,204
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Jul 21 \| 543320	3%	₹7 Cr	287,506
AIA Group Ltd (Financial Services) Equity, Since 31 Mar 12 \| 01299	3%	₹7 Cr	95,600
Larsen & Toubro Ltd (Industrials) Equity, Since 31 Mar 24 \| LT	3%	₹7 Cr	18,306
Indian Hotels Co Ltd (Consumer Cyclical) Equity, Since 30 Apr 23 \| INDHOTEL	3%	₹7 Cr	85,863
HDFC Life Insurance Co Ltd (Financial Services) Equity, Since 31 Jan 24 \| HDFCLIFE	3%	₹6 Cr	81,715

8. DSP BlackRock US Flexible Equity Fund

The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of BGF – USFEF. The Scheme may, at the discretion of the Investment Manager also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized. It shall be noted ‘similar overseas mutual fund schemes’ shall have investment objective, investment strategy and risk profile/consideration similar to those of BGF – USFEF.

DSP BlackRock US Flexible Equity Fund is a Equity - Global fund was launched on 3 Aug 12. It is a fund with High risk and has given a CAGR/Annualized return of 15.5% since its launch. Ranked 3 in Global category. Return for 2024 was 17.8% , 2023 was 22% and 2022 was -5.9% .

Below is the key information for DSP BlackRock US Flexible Equity Fund

DSP BlackRock US Flexible Equity Fund Growth
Launch Date	3 Aug 12
NAV (24 Jul 25)	₹65.0543 ↑ 0.80 (1.24 %)
Net Assets (Cr)	₹935 on 30 Jun 25
Category	Equity - Global
AMC	DSP BlackRock Invmt Managers Pvt. Ltd.
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	1.54
Sharpe Ratio	0.51
Information Ratio	-0.49
Alpha Ratio	-4.34
Min Investment	1,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹14,201
30 Jun 22	₹13,169
30 Jun 23	₹15,997
30 Jun 24	₹19,252
30 Jun 25	₹22,416

DSP BlackRock US Flexible Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹458,689.
Net Profit of ₹158,689 Invest Now

Returns for DSP BlackRock US Flexible Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	4.9%
3 Month	26.5%
6 Month	5.5%
1 Year	20.8%
3 Year	17.4%
5 Year	17%
10 Year
15 Year
Since launch	15.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	17.8%
2023	22%
2022	-5.9%
2021	24.2%
2020	22.6%
2019	27.5%
2018	-1.1%
2017	15.5%
2016	9.8%
2015	2.5%

Fund Manager information for DSP BlackRock US Flexible Equity Fund

Name	Since	Tenure
Jay Kothari	1 Mar 13	12.26 Yr.

Data below for DSP BlackRock US Flexible Equity Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Technology	28.15%
Financial Services	19.4%
Communication Services	14.66%
Health Care	13.24%
Consumer Cyclical	8.96%
Industrials	6.76%
Basic Materials	3.47%
Energy	3.16%

Asset Allocation

Asset Class	Value
Cash	2.18%
Equity	97.81%
Debt	0.01%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BGF US Flexible Equity I2 Investment Fund \| -	99%	₹860 Cr	2,038,389 ↓ -14,475
Treps / Reverse Repo Investments CBLO/Reverse Repo \| -	1%	₹9 Cr
Net Receivables/Payables Net Current Assets \| -	0%	-₹3 Cr

9. HDFC Long Term Advantage Fund

To generate long term capital appreciation from a portfolio that is predominantly in equity and equity related instruments

HDFC Long Term Advantage Fund is a Equity - ELSS fund was launched on 2 Jan 01. It is a fund with Moderately High risk and has given a CAGR/Annualized return of 21.4% since its launch. Ranked 23 in ELSS category. .

Below is the key information for HDFC Long Term Advantage Fund

HDFC Long Term Advantage Fund Growth
Launch Date	2 Jan 01
NAV (14 Jan 22)	₹595.168 ↑ 0.28 (0.05 %)
Net Assets (Cr)	₹1,318 on 30 Nov 21
Category	Equity - ELSS
AMC	HDFC Asset Management Company Limited
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	2.25
Sharpe Ratio	2.27
Information Ratio	-0.15
Alpha Ratio	1.75
Min Investment	500
Min SIP Investment	500
Exit Load	NIL

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹16,322

HDFC Long Term Advantage Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047 Invest Now

Purchase not allowed

Returns for HDFC Long Term Advantage Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	4.4%
3 Month	1.2%
6 Month	15.4%
1 Year	35.5%
3 Year	20.6%
5 Year	17.4%
10 Year
15 Year
Since launch	21.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Fund Manager information for HDFC Long Term Advantage Fund

Name	Since	Tenure

Data below for HDFC Long Term Advantage Fund as on 30 Nov 21

Equity Sector Allocation

Sector	Value

Asset Allocation

Asset Class	Value

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity

10. Aditya Birla Sun Life International Equity Fund - Plan A

An Open-ended diversified equity scheme with an objective to generate long-term growth of capital, by investing predominantly in a diversified portfolio of equity and equity related securities in the international markets

Aditya Birla Sun Life International Equity Fund - Plan A is a Equity - Global fund was launched on 31 Oct 07. It is a fund with High risk and has given a CAGR/Annualized return of 8.5% since its launch. Ranked 36 in Global category. Return for 2024 was 7.4% , 2023 was 8.6% and 2022 was -2.1% .

Below is the key information for Aditya Birla Sun Life International Equity Fund - Plan A

Aditya Birla Sun Life International Equity Fund - Plan A Growth
Launch Date	31 Oct 07
NAV (24 Jul 25)	₹42.1632 ↑ 0.12 (0.27 %)
Net Assets (Cr)	₹215 on 30 Jun 25
Category	Equity - Global
AMC	Birla Sun Life Asset Management Co Ltd
Rating	☆☆
Risk	High
Expense Ratio	2.5
Sharpe Ratio	1.38
Information Ratio	-1.19
Alpha Ratio	6.87
Min Investment	1,000
Min SIP Investment	1,000
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹13,097
30 Jun 22	₹11,868
30 Jun 23	₹13,348
30 Jun 24	₹13,984
30 Jun 25	₹17,652

Aditya Birla Sun Life International Equity Fund - Plan A SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹405,518.
Net Profit of ₹105,518 Invest Now

Returns for Aditya Birla Sun Life International Equity Fund - Plan A

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	4.3%
3 Month	14.9%
6 Month	16.1%
1 Year	27.5%
3 Year	13.3%
5 Year	11.7%
10 Year
15 Year
Since launch	8.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	7.4%
2023	8.6%
2022	-2.1%
2021	13.5%
2020	13.2%
2019	24.7%
2018	4.1%
2017	13.5%
2016	-2.1%
2015	0%

Fund Manager information for Aditya Birla Sun Life International Equity Fund - Plan A

Name	Since	Tenure
Dhaval Joshi	21 Nov 22	2.53 Yr.

Data below for Aditya Birla Sun Life International Equity Fund - Plan A as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Industrials	31.28%
Financial Services	15.98%
Technology	12%
Consumer Defensive	11.56%
Health Care	10.4%
Consumer Cyclical	7.02%
Communication Services	6.51%
Basic Materials	4.33%

Asset Allocation

Asset Class	Value
Cash	0.92%
Equity	99.08%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Rheinmetall AG (Industrials) Equity, Since 31 Aug 24 \| RHM	6%	₹13 Cr	700
Allegro.EU SA Ordinary Shares (Consumer Cyclical) Equity, Since 31 Aug 24 \| ALE	3%	₹6 Cr	80,700
British American Tobacco PLC (Consumer Defensive) Equity, Since 31 Jul 24 \| BATSl	2%	₹5 Cr	12,900
Brambles Ltd (Industrials) Equity, Since 31 Aug 24 \| R1H	2%	₹5 Cr	38,800
Singapore Exchange Ltd (Financial Services) Equity, Since 31 Jul 23 \| SPXCF	2%	₹5 Cr	51,000
Imperial Brands PLC (Consumer Defensive) Equity, Since 31 Oct 21 \| IMB	2%	₹5 Cr	14,600
Corteva Inc (Basic Materials) Equity, Since 31 Aug 24 \| CTVA	2%	₹4 Cr	7,300
Compagnie Financiere Richemont SA Class A (Consumer Cyclical) Equity, Since 29 Feb 24 \| CFR	2%	₹4 Cr	2,700
Veeva Systems Inc Class A (Healthcare) Equity, Since 31 Jul 23 \| VEEV	2%	₹4 Cr	1,800
Tencent Holdings Ltd (Communication Services) Equity, Since 30 Sep 22 \| 00700	2%	₹4 Cr	7,800

11. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a CAGR/Annualized return of 12.5% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% .

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund Growth
Launch Date	28 Dec 15
NAV (25 Jul 25)	₹30.9778 ↑ 0.04 (0.12 %)
Net Assets (Cr)	₹1,282 on 30 Jun 25
Category	Equity - Sectoral
AMC	Tata Asset Management Limited
Rating	Not Rated
Risk	High
Expense Ratio	0
Sharpe Ratio	0.47
Information Ratio	0.73
Alpha Ratio	2.42
Min Investment	5,000
Min SIP Investment	150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Jun 20	₹10,000
30 Jun 21	₹15,403
30 Jun 22	₹13,787
30 Jun 23	₹16,370
30 Jun 24	₹23,471
30 Jun 25	₹27,032

TATA India Pharma & Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹518,033.
Net Profit of ₹218,033 Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Jul 25

Duration	Returns
1 Month	4.2%
3 Month	6%
6 Month	4.8%
1 Year	10.6%
3 Year	24.5%
5 Year	21.8%
10 Year
15 Year
Since launch	12.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40.4%
2023	36.6%
2022	-8%
2021	19.1%
2020	64.4%
2019	5.5%
2018	-2.6%
2017	4.7%
2016	-14.7%
2015

Fund Manager information for TATA India Pharma & Healthcare Fund

Name	Since	Tenure
Meeta Shetty	9 Mar 21	4.23 Yr.
Rajat Srivastava	16 Sep 24	0.71 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 30 Jun 25

Equity Sector Allocation

Sector	Value
Health Care	88.47%
Basic Materials	2.37%

Asset Allocation

Asset Class	Value
Cash	9.16%
Equity	90.84%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	12%	₹143 Cr	854,300
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	6%	₹77 Cr	111,255 ↑ 10,000
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| CIPLA	6%	₹72 Cr	490,000
Aurobindo Pharma Ltd (Healthcare) Equity, Since 30 Apr 20 \| AUROPHARMA	6%	₹71 Cr	615,100
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	6%	₹69 Cr	104,965
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Oct 20 \| FORTIS	5%	₹60 Cr	855,100
Lupin Ltd (Healthcare) Equity, Since 30 Nov 17 \| LUPIN	5%	₹59 Cr	303,240
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Dec 22 \| ASTERDM	4%	₹54 Cr	956,991
Wockhardt Ltd (Healthcare) Equity, Since 31 Mar 24 \| WOCKPHARMA	3%	₹40 Cr	274,871
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 31 Aug 18 \| DRREDDY	3%	₹39 Cr	311,555

Disclaimer:
येथे प्रदान केलेली माहिती अचूक असल्याची खात्री करण्यासाठी सर्व प्रयत्न केले गेले आहेत. तथापि, डेटाच्या अचूकतेबद्दल कोणतीही हमी दिली जात नाही. कृपया कोणतीही गुंतवणूक करण्यापूर्वी योजना माहिती दस्तऐवजासह सत्यापित करा.